Kala Pharmaceuticals Stock Market Value
| KALA Stock | USD 6.75 0.20 2.88% |
| Symbol | Kala |
Kala Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kala Pharmaceuticals. If investors know Kala will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kala Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Kala Pharmaceuticals is measured differently than its book value, which is the value of Kala that is recorded on the company's balance sheet. Investors also form their own opinion of Kala Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kala Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kala Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kala Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kala Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kala Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kala Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Kala Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kala Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kala Pharmaceuticals.
| 12/14/2024 |
| 03/14/2025 |
If you would invest 0.00 in Kala Pharmaceuticals on December 14, 2024 and sell it all today you would earn a total of 0.00 from holding Kala Pharmaceuticals or generate 0.0% return on investment in Kala Pharmaceuticals over 90 days. Kala Pharmaceuticals is related to or competes with Lifecore Biomedical, Shuttle Pharmaceuticals, Journey Medical, Akanda Corp, Organogenesis Holdings, Biofrontera, and China Pharma. Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of... More
Kala Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kala Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kala Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 7.92 | |||
| Information Ratio | 0.0624 | |||
| Maximum Drawdown | 42.84 | |||
| Value At Risk | (6.95) | |||
| Potential Upside | 9.39 |
Kala Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kala Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kala Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Kala Pharmaceuticals historical prices to predict the future Kala Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0452 | |||
| Jensen Alpha | 0.4632 | |||
| Total Risk Alpha | 1.23 | |||
| Sortino Ratio | 0.0497 | |||
| Treynor Ratio | 0.1723 |
Kala Pharmaceuticals Backtested Returns
Kala Pharmaceuticals appears to be unstable, given 3 months investment horizon. Kala Pharmaceuticals has Sharpe Ratio of 0.0616, which conveys that the firm had a 0.0616 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Kala Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please exercise Kala Pharmaceuticals' Risk Adjusted Performance of 0.0452, mean deviation of 4.12, and Downside Deviation of 7.92 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Kala Pharmaceuticals holds a performance score of 4. The company secures a Beta (Market Risk) of 1.55, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Kala Pharmaceuticals will likely underperform. Please check Kala Pharmaceuticals' total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to make a quick decision on whether Kala Pharmaceuticals' current price movements will revert.
Auto-correlation | -0.47 |
Modest reverse predictability
Kala Pharmaceuticals has modest reverse predictability. Overlapping area represents the amount of predictability between Kala Pharmaceuticals time series from 14th of December 2024 to 28th of January 2025 and 28th of January 2025 to 14th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kala Pharmaceuticals price movement. The serial correlation of -0.47 indicates that about 47.0% of current Kala Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.47 | |
| Spearman Rank Test | -0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 2.08 |
Kala Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Kala Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Kala Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Kala Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Kala Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Kala Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Kala Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Kala Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Kala Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Kala Pharmaceuticals Lagged Returns
When evaluating Kala Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Kala Pharmaceuticals stock have on its future price. Kala Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Kala Pharmaceuticals autocorrelation shows the relationship between Kala Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Kala Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Kala Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kala Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kala Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kala Pharmaceuticals Stock:Check out Kala Pharmaceuticals Correlation, Kala Pharmaceuticals Volatility and Kala Pharmaceuticals Alpha and Beta module to complement your research on Kala Pharmaceuticals. For information on how to trade Kala Stock refer to our How to Trade Kala Stock guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Kala Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.